Liver diseases are complex conditions, significantly influenced by oxidative stress. This comprehensive review assesses the therapeutic role of antioxidants like l-ascorbic acid and α tocopherol, beta-carotene, various minerals, and plant-based ingredients in mitigating oxidative stress-induced liver diseases. The manuscript delves into the critical influence of genetic and epigenetic factors on disease susceptibility, progression, and response to antioxidant therapy. While animal studies suggest antioxidant efficacy in liver disease treatment, human trials remain inconclusive, and caution is advised due to its possible potential pro-oxidant effects. Moreover, the interactions of antioxidants with other drugs necessitate careful consideration in the management of polypharmacy in liver disease patients. The review underscores the need for further research to establish the clinical benefits of antioxidants with understanding of possible antioxidant toxicities to elucidate the intricate interplay of genetic, epigenetic, and environmental factors in liver diseases. The aim is to foster a better understanding of the knowledge on hepatic disease management with judicial antioxidant therapies.
Keyphrases
- oxidative stress
- anti inflammatory
- dna methylation
- gene expression
- end stage renal disease
- endothelial cells
- dna damage
- diabetic rats
- genome wide
- induced apoptosis
- ischemia reperfusion injury
- prognostic factors
- stem cells
- copy number
- peritoneal dialysis
- emergency department
- smoking cessation
- human health
- signaling pathway
- electronic health record
- heat stress